Jghomson Pharmaceutical And Dental Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-06-2024
- Paid Up Capital ₹ 0.10 M
as on 23-06-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.50 M
as on 23-06-2024
- Revenue -75.19%
(FY 2020)
- Profit -88.95%
(FY 2020)
- Ebitda 386.90%
(FY 2020)
- Net Worth 0.69%
(FY 2020)
- Total Assets -6.31%
(FY 2020)
About Jghomson Pharmaceutical And Dental Solutions
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Ravindra Lodam, Vedvati Kadu, Avinash Lodam, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85100MH2009PTC194887
- Company No.
194887
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Aug 2009
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Amravati, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jghomson Pharmaceutical And Dental Solutions?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Lodam  | Director | 26-Feb-2015 | Current |
| Ravindra Lodam | Director | 30-Sep-2015 | Current |
| Vedvati Kadu | Director | 30-Sep-2015 | Current |
| Anil Ghom | Director | 12-Aug-2009 | Current |
| Savita Ghom | Director | 12-Aug-2009 | Current |
Financial Performance of Jghomson Pharmaceutical And Dental Solutions.
Jghomson Pharmaceutical And Dental Solutions Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 75.19% decrease. The company also saw a substantial fall in profitability, with a 88.95% decrease in profit. The company's net worth moved up by a moderate rise of 0.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jghomson Pharmaceutical And Dental Solutions?
In 2019, Jghomson Pharmaceutical And Dental Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
City Union Bank Limited Creation Date: 29 Jan 2016 | ₹1.50 M | Open |
How Many Employees Work at Jghomson Pharmaceutical And Dental Solutions?
Unlock and access historical data on people associated with Jghomson Pharmaceutical And Dental Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jghomson Pharmaceutical And Dental Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jghomson Pharmaceutical And Dental Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
